Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yasha Kayan

Neuroradiology Eden Prairie, MN Medical Doctor

NPI 1306056130 CMS profile 104696

7595 Anagram Dr, Ste 400, Eden Prairie, MN 55344

Open in the dashboard

General payments

$860,618

751 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$279,729 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Yasha Kayan of Eden Prairie, MN is reported in the CMS Open Payments database as having received $860,618 across 751 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $279,729 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,269 5
2023 General $6,985 6
2022 General $7,777 7
2021 General $218,013 167
2020 General $429,259 380
2019 General $197,314 186

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yasha Kayan
  • Neuroradiology median
  • Middle half of Neuroradiology
  • National median

In program year 2025, general payments to Yasha Kayan were reported at $1,269. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.

Show as a table
Year Yasha Kayan Neuroradiology median Middle half National median
2019 $197,314 $288 $71–$2,035 $163
2020 $429,259 $165 $32–$1,794 $114
2021 $218,013 $238 $42–$1,807 $132
2022 $7,777 $191 $49–$1,388 $149
2023 $6,985 $228 $56–$1,148 $160
2024 $0 $241 $97–$2,192 $164
2025 $1,269 $279 $65–$2,205 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $779,557 684 payments
  2. Penumbra, Inc. $72,634 48 payments
  3. Medtronic, Inc. $5,319 11 payments
  4. Medtronic USA, Inc. $2,984 7 payments
  5. Smith+Nephew, Inc. $123 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $726,800 129 payments
  2. Travel and Lodging $126,037 498 payments
  3. Food and Beverage $5,782 119 payments
  4. Consulting Fee $1,750 4 payments
  5. Honoraria $249 1 payment
Products named General payments · program years 2019–2025
  1. WEB $550,522 507 payments
  2. WEB Aneurysm Embolization System Neurological Product $214,713 163 payments
  3. Penumbra System $83,279 43 payments
  4. FRED $33,062 11 payments
  5. WEB ANEURYSM EMBOLIZATION SYSTEM Neurological Product $13,889 10 payments
  6. ACE $9,668 10 payments
  7. Axium $3,000 1 payment
  8. Pipeline $2,874 6 payments
  9. Jet 7 $890 6 payments
  10. ONYX 18 $875 2 payments
  11. Other $2,825 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$102,200

Medicare's payments for the services billed

Medicare patients

571

Average age 75

Services billed

1,461

330 women, 241 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 45%
Ischemic heart disease 37%
Depression 34%
Diabetes 30%
Atrial fibrillation 27%
Chronic kidney disease 27%
Heart failure 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

751 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuroradiology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record